{"id":67501,"date":"2020-12-17T09:03:47","date_gmt":"2020-12-17T09:03:47","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=67501"},"modified":"2020-12-17T09:03:47","modified_gmt":"2020-12-17T09:03:47","slug":"nigrostriatal-dopamine-system","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/nigrostriatal-dopamine-system\/","title":{"rendered":"Nigrostriatal dopamine system"},"content":{"rendered":"<p>A group of dopamine-containing neurons that have their cell bodies in the midbrain and their terminals in the basal ganglia, which is part of the extrapyramidal motor system. This pathway deteriorates in Parkinson\u2019s disease and on which antipsychotic drugs act to produce side effects resembling Parkinson\u2019s disease.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A group of dopamine-containing neurons that have their cell bodies in the midbrain and their terminals in the basal ganglia, which is part of the extrapyramidal motor system. This pathway deteriorates in Parkinson\u2019s disease and on which antipsychotic drugs act to produce side effects resembling Parkinson\u2019s disease. &nbsp;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"class_list":["post-67501","post","type-post","status-publish","format-standard","hentry","category-n"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Nigrostriatal dopamine system - Definition of Nigrostriatal dopamine system<\/title>\n<meta name=\"description\" content=\"A group of dopamine-containing neurons that have their cell bodies in the midbrain and their terminals in the basal ganglia, which is part of the extrapyramidal motor system. This pathway deteriorates in Parkinson\u2019s disease and on which antipsychotic drugs act to produce side effects resembling Parkinson\u2019s disease.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/nigrostriatal-dopamine-system\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nigrostriatal dopamine system - Definition of Nigrostriatal dopamine system\" \/>\n<meta property=\"og:description\" content=\"A group of dopamine-containing neurons that have their cell bodies in the midbrain and their terminals in the basal ganglia, which is part of the extrapyramidal motor system. This pathway deteriorates in Parkinson\u2019s disease and on which antipsychotic drugs act to produce side effects resembling Parkinson\u2019s disease.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/nigrostriatal-dopamine-system\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-17T09:03:47+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/nigrostriatal-dopamine-system\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/nigrostriatal-dopamine-system\/\",\"name\":\"Nigrostriatal dopamine system - Definition of Nigrostriatal dopamine system\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2020-12-17T09:03:47+00:00\",\"dateModified\":\"2020-12-17T09:03:47+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"A group of dopamine-containing neurons that have their cell bodies in the midbrain and their terminals in the basal ganglia, which is part of the extrapyramidal motor system. This pathway deteriorates in Parkinson\u2019s disease and on which antipsychotic drugs act to produce side effects resembling Parkinson\u2019s disease.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/nigrostriatal-dopamine-system\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/nigrostriatal-dopamine-system\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/nigrostriatal-dopamine-system\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nigrostriatal dopamine system\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nigrostriatal dopamine system - Definition of Nigrostriatal dopamine system","description":"A group of dopamine-containing neurons that have their cell bodies in the midbrain and their terminals in the basal ganglia, which is part of the extrapyramidal motor system. This pathway deteriorates in Parkinson\u2019s disease and on which antipsychotic drugs act to produce side effects resembling Parkinson\u2019s disease.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/nigrostriatal-dopamine-system\/","og_locale":"en_US","og_type":"article","og_title":"Nigrostriatal dopamine system - Definition of Nigrostriatal dopamine system","og_description":"A group of dopamine-containing neurons that have their cell bodies in the midbrain and their terminals in the basal ganglia, which is part of the extrapyramidal motor system. This pathway deteriorates in Parkinson\u2019s disease and on which antipsychotic drugs act to produce side effects resembling Parkinson\u2019s disease.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/nigrostriatal-dopamine-system\/","og_site_name":"Glossary","article_published_time":"2020-12-17T09:03:47+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/nigrostriatal-dopamine-system\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/nigrostriatal-dopamine-system\/","name":"Nigrostriatal dopamine system - Definition of Nigrostriatal dopamine system","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2020-12-17T09:03:47+00:00","dateModified":"2020-12-17T09:03:47+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"A group of dopamine-containing neurons that have their cell bodies in the midbrain and their terminals in the basal ganglia, which is part of the extrapyramidal motor system. This pathway deteriorates in Parkinson\u2019s disease and on which antipsychotic drugs act to produce side effects resembling Parkinson\u2019s disease.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/nigrostriatal-dopamine-system\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/nigrostriatal-dopamine-system\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/nigrostriatal-dopamine-system\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Nigrostriatal dopamine system"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/67501","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=67501"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/67501\/revisions"}],"predecessor-version":[{"id":67502,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/67501\/revisions\/67502"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=67501"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=67501"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=67501"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}